IBDEI16J ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20060,0)
 ;;=C22.2^^84^929^85
 ;;^UTILITY(U,$J,358.3,20060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20060,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,20060,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,20060,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,20061,0)
 ;;=D58.9^^84^929^87
 ;;^UTILITY(U,$J,358.3,20061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20061,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,20061,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,20061,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,20062,0)
 ;;=C81.99^^84^929^88
 ;;^UTILITY(U,$J,358.3,20062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20062,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,20062,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,20062,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,20063,0)
 ;;=C81.90^^84^929^89
 ;;^UTILITY(U,$J,358.3,20063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20063,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,20063,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,20063,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,20064,0)
 ;;=D89.2^^84^929^90
 ;;^UTILITY(U,$J,358.3,20064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20064,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,20064,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,20064,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,20065,0)
 ;;=D05.12^^84^929^91
 ;;^UTILITY(U,$J,358.3,20065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20065,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,20065,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,20065,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,20066,0)
 ;;=D05.11^^84^929^92
 ;;^UTILITY(U,$J,358.3,20066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20066,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,20066,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,20066,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,20067,0)
 ;;=D05.10^^84^929^93
 ;;^UTILITY(U,$J,358.3,20067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20067,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,20067,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,20067,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,20068,0)
 ;;=D50.0^^84^929^94
 ;;^UTILITY(U,$J,358.3,20068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20068,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,20068,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,20068,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,20069,0)
 ;;=D50.9^^84^929^95
 ;;^UTILITY(U,$J,358.3,20069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20069,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,20069,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,20069,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,20070,0)
 ;;=C46.9^^84^929^96
 ;;^UTILITY(U,$J,358.3,20070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20070,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,20070,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,20070,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,20071,0)
 ;;=C22.0^^84^929^97
 ;;^UTILITY(U,$J,358.3,20071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20071,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,20071,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,20071,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,20072,0)
 ;;=D05.02^^84^929^98
 ;;^UTILITY(U,$J,358.3,20072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20072,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,20072,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,20072,2)
 ;;=^5001928
